Clinical Trial Update: Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial assessed biomarker-guided therapy in advanced non-small cell lung cancer using tumor mRNA levels of ERCC1, RRM1, and BRCA1. The study status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hellenic Oncology Research Group | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: TERMINATED